BioHarvest Sciences Inc.
BHST
$6.55
-$0.05-0.76%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -2.96M | -2.69M | -687.00K | -6.58M | -7.24M |
| Total Depreciation and Amortization | 341.00K | 351.00K | 357.00K | 202.00K | 216.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 605.00K | 603.00K | -972.00K | 5.30M | 4.32M |
| Change in Net Operating Assets | -379.00K | -24.00K | 344.00K | -496.00K | -299.00K |
| Cash from Operations | -2.39M | -1.76M | -958.00K | -1.58M | -2.99M |
| Capital Expenditure | -393.00K | -512.00K | -1.71M | -222.00K | -291.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -7.00K | 40.00K | -225.00K | -- | -- |
| Cash from Investing | -400.00K | -472.00K | -1.93M | -222.00K | -291.00K |
| Total Debt Issued | 3.31M | -- | -- | -- | 7.10M |
| Total Debt Repaid | -860.00K | -164.00K | -119.00K | -129.00K | -90.00K |
| Issuance of Common Stock | 0.00 | 0.00 | 4.73M | 13.00K | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 2.45M | -164.00K | 4.61M | -116.00K | 7.01M |
| Foreign Exchange rate Adjustments | -43.00K | -5.00K | 17.00K | -3.00K | 72.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -378.00K | -2.40M | 1.73M | -1.92M | 3.80M |